AVENUE SOLUTIONS for MERCK & CO. INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Antibiotics/stewardship; Value of prescription drugs; Issues related to Title X and women's preventative health services S. 1712, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRACY SPICER | — |
Medicare/Medicaid MMM
Issues relating to the further development of antibiotics and antimicrobials for serious and unmet medical needs; Antibiotics/stewardship; S. 1712, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; Value of prescription drugs; Issues related to Medicare Parts B and D; Biosimilars policies; Medicaid AMP (Average Manufacturer Price) cap
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRACY SPICER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.